Qure.ai (Qure) one of the leading health tech firms using Artificial Intelligence (AI) for medical imaging diagnostics, said that it has secured $40 million in a funding round led by Novo Holdings and HealthQuad, supported by existing investor MassMutual Ventures. Qure.ai will use the new investment to extend and strengthen its global reach, especially in the US and Europe, and intensify product development for critical care and community diagnostics.
"Every year our technology helps more than four million people across 50 countries. Our goal is to continue being bullish in our market expansion, especially in the US and Europe,” said Prashant Warier, CEO and founder, Qure.ai. “We are committed to aiding healthcare professionals in diagnosing illnesses faster and with more detail